BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1516031)

  • 1. Prognostic factors. Stage and receptor status in breast cancer.
    Donegan WL
    Cancer; 1992 Sep; 70(6 Suppl):1755-64. PubMed ID: 1516031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.
    Masood S
    Surg Oncol Clin N Am; 1995 Oct; 4(4):601-32. PubMed ID: 8535901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer.
    Reiner A; Kolb R; Reiner G; Jakesz R; Schemper M; Spona J
    J Cancer Res Clin Oncol; 1987; 113(3):285-90. PubMed ID: 3584218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors in breast cancer--classification in non-university hospitals].
    Willner J; Kiricuta IC; Kölbl O; Bohndorf W
    Zentralbl Chir; 1993; 118(9):525-31. PubMed ID: 8237148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
    Friedman NS; Freedman MD
    Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
    Partin JF; Mamounas EP
    Ann Surg Oncol; 2011 Nov; 18(12):3399-406. PubMed ID: 21537874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
    Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
    Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of presence of progesterone receptors to prognosis in early breast cancer.
    Pichon MF; Pallud C; Brunet M; Milgrom E
    Cancer Res; 1980 Sep; 40(9):3357-60. PubMed ID: 7427948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic factors in medullary breast cancer].
    Mitze M; Goepel E
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer.
    Silvestrini R; Daidone MG; Luisi A; Boracchi P; Mezzetti M; Di Fronzo G; Andreola S; Salvadori B; Veronesi U
    J Clin Oncol; 1995 Mar; 13(3):697-704. PubMed ID: 7884430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
    Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
    Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative importance of estrogen and progesterone receptor assays as prognostic indicators in primary breast cancer: a short-term study.
    Brocklehurst D; Wilde CE; Finbow JA; Brett R; Champion AE; Dewhurst DG
    Clin Chem; 1989 Feb; 35(2):238-40. PubMed ID: 2914367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic indicators in node-negative early stage breast cancer.
    Wong WW; Vijayakumar S; Weichselbaum RR
    Am J Med; 1992 May; 92(5):539-48. PubMed ID: 1580300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.